GENETIC PREDICTORS OF SEVERITY AND EFFICACY OF COVID-19 PHARMACOTHERAPY

被引:1
作者
Shishimorov, I. N. [1 ]
Magnitskaya, O., V [1 ]
Ponomareva, Yu, V [1 ]
机构
[1] Volgograd State Med Univ, Inst Continuing Med & Pharmaceut Educ, Dept Pediat & Neonatol, 1 Pavshikh Bortsov Sq, Volgograd 400131, Russia
来源
PHARMACY & PHARMACOLOGY-FARMATSIYA I FARMAKOLOGIYA | 2021年 / 9卷 / 03期
关键词
COVID-19; pharmacotherapy; gene polymorphism; pharmacogenetics; SARS-CoV-2; predictors; RECEPTOR; POLYMORPHISMS; CORONAVIRUS; PHARMACOGENETICS; ASSOCIATION; EXPRESSION; DISEASE; NR3C1;
D O I
10.19163/2307-9266-2021-9-3-174-184
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pandemic of the novel coronavirus infection 2019 (COVID-19) has changed many aspects of our lives and initiated numerous studies aimed at finding the factors that determine different courses of this infectious disease. The studies aimed at finding predictors of the severe course of this novel coronavirus infection, as well as the factors that determine the efficacy and safety of this disease pharmacotherapy, are acquiring special social significance. The aim of this work is to find and summarize information on genetic predictors of severe COVID-19, as well as pharmacogenetic aspects that determine the variability of the therapeutic response to the drugs recommended for COVID-19 treatment. Materials and methods. The article provides a review of scientific results on the research of gene polymorphism that determine a body's response to the introduction of SARS-CoV-2 infection and the effects of pharmacotherapy for this disease, obtained from open and available sources within the period of 2019 - March 2021. The search was conducted in the following electronic databases: PubMed, Cochrane Library, ClinicalTrials.gov; Elibrary, Scopus. The main search inquiries were: "predictors + severe course + COVID-19", "genetic variations + COVID-19", "pharmacogenetics + COVID-19", "gene polymorphism + SARS-CoV-2", "pharmacotherapy + gene polymorphism + COVID-19" in both Russian and English. Results and conclusion. The exploratory research detailing the mechanisms of infecting with SARS-CoV-2, the variability of the disease severity and the individual characteristics of therapeutic responses to the drugs used, are being actively carried out by scientists all over the world. However, most of their scientific projects are diverse, and the possible predictors of a severe course of COVID-19 found in them, have not been confirmed or investigated in subsequent studies. A generalization of the individual studies results of the genetic predictors concerning COVID-19 severity and effectiveness of its pharmacotherapy, can become the basis for further search and increase the reliability of the data obtained in order to develop a strategy for preventing the spread of COVID-19 infection, to identify potential targets of the treatment, and develop the protocols for optimizing this disease pharmacotherapy.
引用
收藏
页码:174 / 184
页数:11
相关论文
共 57 条
[1]   Mortality in patients admitted to intensive care with COVID-19: an updated systematic review and meta-analysis of observational studies [J].
Armstrong, R. A. ;
Kane, A. D. ;
Kursumovic, E. ;
Oglesby, F. C. ;
Cook, T. M. .
ANAESTHESIA, 2021, 76 (04) :537-548
[2]   Autoantibodies against type I IFNs in patients with life-threatening COVID-19 [J].
Bastard, Paul ;
Rosen, Lindsey B. ;
Zhang, Qian ;
Michailidis, Eleftherios ;
Hoffmann, Hans-Heinrich ;
Zhang, Yu ;
Dorgham, Karim ;
Philippot, Quentin ;
Rosain, Jeremie ;
Beziat, Vivien ;
Manry, Jeremy ;
Shaw, Elana ;
Haljasmagi, Liis ;
Peterson, Part ;
Lorenzo, Lazaro ;
Bizien, Lucy ;
Trouillet-Assant, Sophie ;
Dobbs, Kerry ;
de Jesus, Adriana Almeida ;
Belot, Alexandre ;
Kallaste, Anne ;
Catherinot, Emilie ;
Tandjaoui-Lambiotte, Yacine ;
Le Pen, Jeremie ;
Kerner, Gaspard ;
Bigio, Benedetta ;
Seeleuthner, Yoann ;
Yang, Rui ;
Bolze, Alexandre ;
Spaan, Andras N. ;
Delmonte, Ottavia M. ;
Abers, Michael S. ;
Aiuti, Alessandro ;
Casari, Giorgio ;
Lampasona, Vito ;
Piemonti, Lorenzo ;
Ciceri, Fabio ;
Bilguvar, Kaya ;
Lifton, Richard P. ;
Vasse, Marc ;
Smadja, David M. ;
Migaud, Melanie ;
Hadjadj, Jerome ;
Terrier, Benjamin ;
Duffy, Darragh ;
Quintana-Murci, Lluis ;
van de Beek, Diederik ;
Roussel, Lucie ;
Vinh, Donald C. ;
Tangye, Stuart G. .
SCIENCE, 2020, 370 (6515) :423-+
[3]   INTERLEUKIN 6 (RS1800795) GENE POLYMORPHISM IS ASSOCIATED WITH CARDIOVASCULAR DISEASES: A META-ANALYSIS OF 74 STUDIES WITH 86,229 SUBJECTS [J].
Beatriz Gonzalez-Castro, Thelma ;
Hernandez-Diaz, Yazmin ;
Perez-Hernandez, Nonanzit ;
Alfonso Tovilla-Zarate, Carlos ;
Juarez-Rojop, Isela Esther ;
Lilia Lopez-Narvaez, Maria ;
Blachman-Braun, Ruben ;
Posadas-Sanchez, Rosalinda ;
Vargas-Alarcon, Gilberto ;
Garcia-Flores, Esbeidy ;
Giovanni Cazarin-Santos, Benny ;
Marusa Borgonio-Cuadra, Veronica ;
Reyes-Lopez, Pedro A. ;
Manuel Rodriguez-Perez, Jose .
EXCLI JOURNAL, 2019, 18 :331-355
[4]   Remdesivir for the Treatment of Covid-19-Final Report [J].
Beigel, John H. ;
Tomashek, Kay M. ;
Dodd, Lori E. ;
Mehta, Aneesh K. ;
Zingman, Barry S. ;
Kalil, Andre C. ;
Hohmann, Elizabeth ;
Chu, Helen Y. ;
Luetkemeyer, Annie ;
Kline, Susan ;
de Castilla, Diego Lopez ;
Finberg, Robert W. ;
Dierberg, Kerry ;
Tapson, Victor ;
Hsieh, Lanny ;
Patterson, Thomas F. ;
Paredes, Roger ;
Sweeney, Daniel A. ;
Short, William R. ;
Touloumi, Giota ;
Lye, David Chien ;
Ohmagari, Norio ;
Oh, Myoung-don ;
Ruiz-Palacios, Guillermo M. ;
Benfield, Thomas ;
Faetkenheuer, Gerd ;
Kortepeter, Mark G. ;
Atmar, Robert L. ;
Creech, C. Buddy ;
Lundgren, Jens ;
Babiker, Abdel G. ;
Pett, Sarah ;
Neaton, James D. ;
Burgess, Timothy H. ;
Bonnett, Tyler ;
Green, Michelle ;
Makowski, Mat ;
Osinusi, Anu ;
Nayak, Seema ;
Lane, H. Clifford .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (19) :1813-1826
[5]   Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020) [J].
Bhimraj, Adarsh ;
Morgan, Rebecca L. ;
Shumaker, Amy Hirsch ;
Lavergne, Valery ;
Baden, Lindsey ;
Cheng, Vincent Chi-Chung ;
Edwards, Kathryn M. ;
Gandhi, Rajesh ;
Muller, William J. ;
O'Horo, John C. ;
Shoham, Shmuel ;
Murad, M. Hassan ;
Mustafa, Reem A. ;
Sultan, Shahnaz ;
Falck-Ytter, Yngve .
CLINICAL INFECTIOUS DISEASES, 2020, 78 (07) :e83-e102
[6]   Variations of the human glucocorticoid receptor gene (NR3C1): Pathological and in vitro mutations.and polymorphisms [J].
Bray, PJ ;
Cotton, RGH .
HUMAN MUTATION, 2003, 21 (06) :557-568
[7]  
Chiche Jean-Daniel, 2001, Sepsis (Boston), V4, P209, DOI 10.1023/A:1013222407924
[8]   The HLA system: Genetics, immunology, clinical testing, and clinical implications [J].
Choo, Sung Yoon .
YONSEI MEDICAL JOURNAL, 2007, 48 (01) :11-23
[9]   CRP/IL-6/IL-10 Single-Nucleotide Polymorphisms Correlate with the Susceptibility and Severity of Community-Acquired Pneumonia [J].
Chou, Shou-Chu ;
Ko, How-Wen ;
Lin, Ying-Chin .
GENETIC TESTING AND MOLECULAR BIOMARKERS, 2016, 20 (12) :732-740
[10]   Association Between N363S and Bcl/Polymorphisms of the Glucocorticoid Receptor Gene (NR3C1) and Glucocorticoid Side Effects During Childhood Acute Lymphoblastic Leukemia Treatment [J].
Cihan, Meric Kaymak ;
Karabulut, Halil Gurhan ;
Kutlay, Nuket Yurur ;
Ruhi, Hatice Ilgin ;
Tukun, Ajlan ;
Olcay, Lale .
TURKISH JOURNAL OF HEMATOLOGY, 2017, 34 (02) :151-158